About KeraLink International

We envision a world free of corneal blindness where cutting-edge, affordable solutions reach every corner of the globe, ensuring no individual is denied the right to sight. By uniting clinicians, technology innovators, governmental and non-governmental organizations, social entrepreneurs, and donors, we aim to make this vision a reality, making comprehensive cornea care accessible and sustainable for all.

Our Mission

Helping Where Needed

Having transformed the landscape of corneal treatment in the U.S., KeraLink International has pivoted its expertise globally.

Original U.S. Mission: Complete

KeraLink International helped transform the landscape of corneal treatment by eliminating waiting lists for cornea transplants in the U.S.

Today We Aim To Help LMICs: Starting in India

In India, reports show an estimated 7 million people have corneal blindness in at least one eye. We want to start here.

Our Vision

We Envision a World Free of Corneal Blindness

Where cutting-edge, affordable solutions reach every corner of the globe, ensuring that no individual is denied the right to sight. By uniting clinicians, technology innovators, social entrepreneurs, and donors, we aim to turn this vision into a reality, making comprehensive cornea care accessible and sustainable for all.

No one needs to be blind due to corneal disease
or injury.

Our History

1962

KLI was founded as the Medical Eye Bank of Maryland.

1962

1980s

KLI became Tissue Banks International and assisted in opening 48 eye banks in 24 countries. KLI became the world’s largest ocular tissue supplier.
1980s

1990s

Mission accomplished: KLI helped eliminate waiting lists for cornea transplants in the US, effectively eradicating untreated corneal blindness in the U.S.
1990s

2010s

KLI realized that what worked in high-income countries to eradicate corneal blindness would not work in LMICs.

2010s

2019

KLI sold its eye banks to focus solely on harnessing the power of new and emerging technologies to eradicate corneal blindness globally in ways not possible before.

2019

2023

KLI launched Pantheon Vision to develop bioengineered corneal implants for use in LMICs and other countries to reduce reliance on human donor tissue.
2023

2023

Today, KLI is the only organization bringing clinicians, technology innovators, healthcare providers, philanthropists, and investors into a coordinated, collaborative effort to eradicate corneal blindness in LMICs.
2023
Scroll to Top